One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: IFL/FOLFOX/IROX in Advanced Colorectal Cancer and FOLFIRI and FOLFOX6 in Colorectal Cancer.
Venook, Alan P. MD, FASCO 1,2,,
doi : 10.1200/JCO.23.00324
Volume 41(19) pgs. 3459-3561 July 1, 2023
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer .
Goldberg, Richard M.; Sargent, Daniel J.; Morton, Roscoe F.; Fuchs, Charles S.; Ramanathan, Ramesh K.; Williamson, Stephen K.; Findlay, Brian P.; Pitot, Henry C.; Alberts, Steven R.
doi : 10.1200/JCO.22.02759
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study.
Tournigand, Christophe; Andre[Combining Acute Accent], Thierry; Achille, Emmanuel; Lledo, Ge[Combining Acute Accent]rard; Flesh, Michel; Mery-Mignard, Dominique; Quinaux, Emmanuel; Couteau, Corinne; Buyse, Marc; Ganem, Ge[Combining Acute Accent]rard; Landi, Bruno; Colin, Philippe; Louvet, Christophe; de Gramont, Aimery
doi : 10.1200/JCO.22.02774
A New Look as JCO Looks to the Future.
Miller, Kathy D. MD 1,,; Cochran, Angela 2,; Gunn, Emilie 2,; Friedberg, Jonathan W. MD 3,
doi : 10.1200/JCO.23.00796
Use of Large Language Models and Artificial Intelligence Tools in Works Submitted to Journal of Clinical Oncology.
Miller, Kathy MD 1,2,,; Gunn, Emilie 2,; Cochran, Angela 2,; Burstein, Hal MD, PhD, FACP 2,3,; Friedberg, Jonathan W. MD 2,4,; Wheeler, Stephanie MPH, PhD 2,5,; Frankel, Paul PhD 2,6,
doi : 10.1200/JCO.23.00819
Optimizing Pediatric Leukemia Care in Countries With Limited Resources.
Ribeiro, Raul C. MD 1,2,; Conter, Valentino MD 3,
doi : 10.1200/JCO.23.00451
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After >=2 Years of Follow-Up.
Powles, Thomas MD, PhD 1,,; Park, Se Hoon MD, PhD 2,; Caserta, Claudia MD 3; Valderrama, Begona P. MD 4,; Gurney, Howard MBBS 5,; Ullen, Anders MD, PhD 6,7,; Loriot, Yohann MD, PhD 8,; Sridhar, Srikala S. MD 9,; Sternberg, Cora N. MD 10,; Bellmunt, Joaquim MD, PhD 11,; Aragon-Ching, Jeanny B. MD 12,; Wang, Jing PhD 13,; Huang, Bo PhD 14,; Laliberte, Robert J. MS 13,; di Pietro, Alessandra MD, PhD 15,; Grivas, Petros MD, PhD 16,
doi : 10.1200/JCO.22.01792
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases.
Siva, Shankar PhD 1,2,,; Sakyanun, Pitchaya MD 3; Mai, Tao PhD 4; Wong, Wenchang MBBS 5,; Lim, Adeline MBBS 6; Ludbrook, Joanna MBChB 7,; Bettington, Catherine MBBS 8,; Rezo, Angela MBBS 9,; Pryor, David MBBS 4,; Hardcastle, Nicholas PhD 2,10,; Kron, Tomas PhD 2,10,; Higgs, Braden MBBS 11; Le, Hien MBBS 11; Skala, Marketa MBBS 12; Gill, Suki MBBS 13; Eade, Thomas MBBS 14; Awad, Raef MD 12; Sasso, Giuseppe MBChB 15,; Vinod, Shalini MD 16,; Montgomery, Rebecca BBiomedSc 17; Ball, David MD 1,2,; Bressel, Mathias MSc 2,18
doi : 10.1200/JCO.23.00150
Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Munster 2009 Trial.
Campbell, Myriam MD, PhD 1,; Kiss, Csongor MD, PhD 2,; Zimmermann, Martin PhD 3; Riccheri, Cecilia MD, PhD 4; Kowalczyk, Jerzy MD, PhD 5; Felice, Maria S. MD, PhD 6; Kuzmanovic, Milos MD, PhD 7; Kovacs, Gabor MD, PhD 8; Kosmidis, Helen MD, PhD 9; Gonzalez, Alejandro MD, PhD 10,+; Bilic, Ernest MD, PhD 11; Castillo, Luis MD, PhD 12; Kolenova, Alexandra MD, PhD 13,; Jazbec, Janez MD, PhD 14; Popa, Alexander MD, PhD 15; Konstantinov, Dobrin MD, PhD 16,; Kappelmayer, Janos PhD 17; Szczepanski, Tomasz MD, PhD 18,; Dworzak, Michael MD, PhD 19; Buldini, Barbara PhD 20,; Gaipa, Giuseppe PhD 21; Marinov, Neda MT 22,23; Rossi, Jorge PhD 24; Nagy, Attila PhD 25; Gaspar, Imre MD, PhD 26; Stary, Jan MD, PhD 27; Schrappe, Martin MD, PhD 28,
doi : 10.1200/JCO.22.01760
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
Lubberts, Sjoukje MD 1; Groot, Harmke J. MD, PhD 2; de Wit, Ronald MD, PhD 3,; Mulder, Sasja MD, PhD 4,; Witjes, Johannes A. MD, PhD 5,; Kerst, J. Martijn MD, PhD 6; Groenewegen, Gerard MD, PhD 7; Lefrandt, Joop D. MD, PhD 8; van Leeuwen, Flora E. PhD 2; Nuver, Janine MD, PhD 1; Schaapveld, Michael PhD 2; Gietema, Jourik A. MD, PhD 1,
doi : 10.1200/JCO.22.01016
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Cartron, Guillaume MD, PhD 1,,; Bachy, Emmanuel MD, PhD 2,; Tilly, Herve MD 3; Daguindau, Nicolas MD 4; Pica, Gian-Matteo MD 5; Bijou, Fontanet MD 6; Mounier, Christiane MD 7; Clavert, Aline MD 8,; Damaj, Gandhi Laurent MD, PhD 9,; Slama, Borhane MD 10; Casasnovas, Olivier MD 11,; Houot, Roch MD, PhD 12,; Bouabdallah, Krimo MD 13; Sibon, David MD, PhD 14,; Fitoussi, Olivier MD 15; Morineau, Nadine MD 16; Herbaux, Charles MD, PhD 1,; Gastinne, Thomas MD 17,; Fornecker, Luc-Matthieu MD 18,; Haioun, Corinne MD, PhD 19,; Launay, Vincent MD 20; Araujo, Carla MD 21; Benbrahim, Omar MD 22; Sanhes, Laurence MD 23; Gressin, Remy MD 24,; Gonzalez, Hugo MD 25; Morschhauser, Franck MD, PhD 26,; Ternant, David PhD 27,; Xerri, Luc MD, PhD 28,; Tarte, Karin PhD 29,; Pranger, Delphine MD 30
doi : 10.1200/JCO.22.02327
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Harrison, Claire N. DM, FRCP 1,,; Nangalia, Jyoti MB BChir, PhD 2,3,4,; Boucher, Rebecca PhD 5; Jackson, Aimee MSc 5; Yap, Christina PhD 5,6,; O'Sullivan, Jennifer MB BCh BAO 1,7; Fox, Sonia BSc 5; Ailts, Isaak MD 8; Dueck, Amylou C. PhD 9; Geyer, Holly L. MD 8; Mesa, Ruben A. MD, FACP 10,; Dunn, William G. MB ChB 4; Nadezhdin, Eugene PhD 3,; Curto-Garcia, Natalia MB BCh, MRCPath 1; Green, Anna MB BS 1,; Wilkins, Bridget PhD, MRCPath 1; Coppell, Jason MBBS 11,; Laurie, John MBChB, MRCPath 12,; Garg, Mamta MB, FRCP, FRCPath 13,; Ewing, Joanne MD, PhD 14,; Knapper, Steven BMBCh, FRCPath 15,; Crowe, Josephine MBBS, MRCPath 16; Chen, Frederick PhD, FRCP, FRCPath 17,; Koutsavlis, Ioannis MB, FRCPath 18,; Godfrey, Anna BMBCh, PhD 4,; Arami, Siamak MD, FRCPath 19,; Drummond, Mark PhD, FRCPath 20,; Byrne, Jennifer PhD, FRCPath 21,; Clark, Fiona MB, FRCP, FRCPath 17; Mead-Harvey, Carolyn MS 9; Baxter, Elizabeth Joanna PhD 22; McMullin, Mary Frances MD, FRCP, FRCPath 23,; Mead, Adam J. MB BChir, PhD 7,24,
doi : 10.1200/JCO.22.01935
The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
O'Connor, David PhD, MBChB 1,2,,; Demeulemeester, Jonas PhD 3,4,5; Conde, Lucia PhD 1; Kirkwood, Amy MSc 6,; Fung, Kent PhD 1; Papaleonidopoulou, Foteini MSc 1,3; Bloye, Gianna MSc 1; Farah, Nadine PhD, MBChB 1,; Rahman, Sunniyat PhD 1,7,8; Hancock, Jeremy PhD 9; Bateman, Caroline PhD, MBBS 10; Inglott, Sarah BSc 2; Mee, Jon BSc 11; Herrero, Javier PhD 1; Van Loo, Peter PhD 3,12,13; Moorman, Anthony V. PhD 14,; Vora, Ajay MD 2,; Mansour, Marc R. PhD, MBChB 1,15,
doi : 10.1200/JCO.22.02734
Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?.
Strach, Madeleine C. MBBS, MPH, FRACP; Mahon, Kate MBBS, PhD, FRACP; Barriuso, Jorge MD, PhD, MSc
doi : 10.1200/JCO.22.02895
Reply to M.C. Strach et al.
Foote, Michael B. MD; Nash, Garrett M. MD, MPH; Cercek, Andrea MD
doi : 10.1200/JCO.23.00271
